Spouting Rock Asset Management, LLC Invitae Corp Transaction History

Spouting Rock Asset Management, LLC

  • $273 Million
  • Q4 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$6.28 - $15.59 $99,864 - $247,912
-15,902 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$14.7 - $28.67 $38,293 - $74,685
2,605 Added 19.59%
15,902 $243,000
Q3 2021

Nov 15, 2021
SELL
$24.31 - $33.6 $28,588 - $39,513
-1,176 Reduced 8.13%
13,297 $378,000
Q2 2021

Aug 16, 2021
BUY
$26.09 - $40.4 $78,609 - $121,725
3,013 Added 26.29%
14,473 $488,000
Q1 2021

May 17, 2021
BUY
$33.06 - $56.93 $378,867 - $652,417
11,460 New
11,460 $438,000

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Spouting Rock Asset Management, LLC Portfolio

Follow Spouting Rock Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email